27 results  1 of 2 

1 Different Molecular Phenotypes of Progression in BRAF- and RAS-Like Papillary Thyroid Carcinoma
Jinsun Lim, Han Sai Lee, Jiyun Park, Kyung-Soo Kim, Soo-Kyung Kim, Yong-Wook Cho, Young Shin Song
Endocrinol Metab.2023;38(4):445-454.   Published online 2023 July 18     DOI: http://dx.doi.org/10.3803/EnM.2023.1702
      
2 The Role of Hypoxia in Brain Tumor Immune Responses
Jang Hyun Park, Heung Kyu Lee
Brain Tumor Res Treat.2023;11(1):39-46.   Published online 2023 January 30     DOI: http://dx.doi.org/10.14791/btrt.2022.0043
      
3 Molecular Biology of Brain Metastases
Ho-Shin Gwak
Brain Tumor Res Treat.2023;11(1):8-15.   Published online 2023 January 30     DOI: http://dx.doi.org/10.14791/btrt.2022.0045
      
4 A clinical and pathological update on hepatocellular carcinoma
Salvatore Lorenzo Renne, Luca Di Tommaso
J Liver Cancer.2022;22(1):14-22.   Published online 2022 March 31     DOI: http://dx.doi.org/10.17998/jlc.2022.03.18
      
5 Signature of arylacetamide deacetylase expression is associated with prognosis and immune infiltration in ovarian cancer
Jianyang Feng, Hong He
Obstet Gynecol Sci.2022;65(1):52-63.   Published online 2022 January 15     DOI: http://dx.doi.org/10.5468/ogs.21237
      
6 Cooperative Subtype Switch of Thyroid Hormone Receptor and Nuclear Receptor Corepressor Related Epithelial–Mesenchymal Transition in Papillary Thyroid Cancer
Seonhyang Jeong, Seul Gi Lee, Hyunji Kim, Gibbeum Lee, Sunmi Park, In-Kyu Kim, Jandee Lee, Young Suk Jo
Int J Thyroidol.2021;14(2):152-169.   Published online 2021 November 30     DOI: http://dx.doi.org/10.11106/ijt.2021.14.2.152
      
7 Histone Deacetylase as a Valuable Predictive Biomarker and Therapeutic Target in Immunotherapy for Non–Small Cell Lung Cancer
Hyun-Seock Shin, Juwhan Choi, Jinhwan Lee, Sung Yong Lee
Cancer Res Treat.2022;54(2):458-468.   Published online 2021 September 10     DOI: http://dx.doi.org/10.4143/crt.2021.425
      
8 Circulating microRNAs as biomarkers in bile-derived exosomes of cholangiocarcinoma
Jin-Yi Han, Keun Soo Ahn, Yong Hoon Kim, Tae-Seok Kim, Won-Ki Baek, Seong-Il Suh, Koo Jeong Kang
Ann Surg Treat Res.2021;101(3):140-150.   Published online 2021 August 31     DOI: http://dx.doi.org/10.4174/astr.2021.101.3.140
      
9 Prospects for Manipulation of Mesenchymal Stem Cells in Tumor Therapy: Anti-Angiogenesis Property on the Spotlight
Marzieh Ghollasi, Shahram Ghasembaglou, Dariush Rahban, Mohsen Korani, Morteza Motallebnezhad, Milad Asadi, Habib Zarredar, Ali Salimi
Int J Stem Cells.2021;14(4):351-365.   Published online 2021 August 31     DOI: http://dx.doi.org/10.15283/ijsc20146
      
10 Tumor Cells and Cancer-Associated Fibroblasts: A Synergistic Crosstalk to Promote Thyroid Cancer
Laura Fozzatti, Sheue-yann Cheng
Endocrinol Metab.2020;35(4):673-680.   Published online 2020 November 9     DOI: http://dx.doi.org/10.3803/EnM.2020.401
      
11 Forkhead Box C1 (FOXC1) Expression in Stromal Cells within the Microenvironment of T and NK Cell Lymphomas: Association with Tumor Dormancy and Activation
Ji Hae Nahm, Woo Ick Yang, Sun Och Yoon
Cancer Res Treat.2020;52(4):1273-1282.   Published online 2020 July 3     DOI: http://dx.doi.org/10.4143/crt.2020.032
      
12 Heterogeneity of Human γδ T Cells and Their Role in Cancer Immunity
Hye Won Lee, Yun Shin Chung, Tae Jin Kim
Immune Netw.2020;20(1):e5.  Published online 2020 February 14     DOI: http://dx.doi.org/10.4110/in.2020.20.e5
      
13 Regulatory T Cells in Tumor Microenvironment and Approach for Anticancer Immunotherapy
Jung-Ho Kim, Beom Seok Kim, Sang-Kyou Lee
Immune Netw.2020;20(1):e4.  Published online 2020 February 11     DOI: http://dx.doi.org/10.4110/in.2020.20.e4
      
14 IL-17-Producing Cells in Tumor Immunity: Friends or Foes?
Da-Sol Kuen, Byung-Seok Kim, Yeonseok Chung
Immune Netw.2020;20(1):e6.  Published online 2020 February 7     DOI: http://dx.doi.org/10.4110/in.2020.20.e6
      
15 Regulatory T Cells in Tumor Microenvironment and Approach for Anticancer Immunotherapy
Jung-Ho Kim, Beom Seok Kim, Sang-Kyou Lee
Immune Netw.2020;20(1):e4.  Published online 2020 February 4     DOI: http://dx.doi.org/10.4110/in.2020.20.e4
      
16 Heterogeneity of Human γδ T Cells and Their Role in Cancer Immunity
Hye Won Lee, Yun Shin Chung, Tae Jin Kim
Immune Netw.2020;20(1):e5.  Published online 2020 February 4     DOI: http://dx.doi.org/10.4110/in.2020.20.e5
      
17 IL-17-Producing Cells in Tumor Immunity: Friends or Foes?
Da-Sol Kuen, Byung-Seok Kim, Yeonseok Chung
Immune Netw.2020;20(1):e6.  Published online 2020 February 4     DOI: http://dx.doi.org/10.4110/in.2020.20.e6
      
18 Role of Immunosuppressive Microenvironment in Acquiring Immunotolerance Post-Photothermal Therapy
Kondareddy Cherukula, Myung Suk Park, Adonijah Graham Sontyana, Ansuja Pulickal Mathew, Veena Vijayan, Woo Kyun Bae, In-Kyu Park
J Korean Med Sci.2019;34(44):e272.  Published online 2019 October 10     DOI: http://dx.doi.org/10.3346/jkms.2019.34.e272
      
19 High-Throughput Multiplex Immunohistochemical Imaging of the Tumor and Its Microenvironment
Jiwon Koh, Yoonjin Kwak, Jin Kim, Woo Ho Kim
Cancer Res Treat.2020;52(1):98-108.   Published online 2019 May 27     DOI: http://dx.doi.org/10.4143/crt.2019.195
      
20 IL-12 Enhances Immune Response by Modulation of Myeloid Derived Suppressor Cells in Tumor Microenvironment
Ji-Na Choi, Eun Gene Sun, Sang-Hee Cho
Chonnam Med J.2019;55(1):31-39.   Published online 2019 January 25     DOI: http://dx.doi.org/10.4068/cmj.2019.55.1.31
      

 1 of 2